BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 7, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 25, 2005
View Archived Issues
Pfizer Buys More, Gains Caspase Inhibitors Through Idun Purchase
Although it had plenty of money in the bank, Idun Pharmaceuticals Inc. made a strategic decision to become part of a big pharmaceutical company that will help advance its lead liver disease product. (BioWorld Today)
Read More
Analyst: Pharma Returns To Antibodies, At Times Too Late
Read More
Pharsight Software Used For FDA's Critical Path Initiative
Read More
Agreement Brings Prolexys Antitumor Compound Rights
Read More
Other News To Note
Read More